The short answer is neither. NAD+ supplements reliably raise blood levels of NAD+, a molecule that declines roughly twofold by middle age, but the evidence that popping a pill translates into meaningful anti-aging benefits in humans remains weak and inconsistent. If you are considering these supplements for brain health or dementia prevention specifically, you should know that no published clinical trial has demonstrated cognitive improvements in healthy older adults from NAD+ precursors alone. A recent meta-analysis of randomized controlled trials confirmed that while NMN significantly elevates blood NAD+ levels, most clinically relevant outcomes were not significantly different from placebo groups.
That does not mean the science is worthless. A 12-week randomized trial found that 250 mg per day of NMN improved sleep quality and walking speed in older adults, and a double-blind, placebo-controlled trial published in The Lancet eClinicalMedicine in November 2025 evaluated nicotinamide riboside at 2,000 mg per day for long-COVID, including its effects on cognition and symptom recovery. These are real studies with real endpoints. But the gap between what animal research promises and what human trials deliver has been wide and persistent, and the field is tangled up in commercial interests that make objective evaluation difficult. This article breaks down what the clinical evidence actually shows, who profits from the hype, what the supplements cost, and what someone concerned about brain aging should realistically expect.
Table of Contents
- What Are NAD+ Supplements and Do They Actually Slow Aging?
- What the Latest Clinical Trials Actually Found
- The Financial Conflicts Behind the NAD+ Debate
- How Much Do NAD+ Supplements Cost and Are They Worth the Price?
- Regulatory Chaos and What the FDA’s Reversal Means for Consumers
- NAD+ and Brain Health — What Dementia Caregivers Should Know
- Where the Science Goes From Here
- Conclusion
- Frequently Asked Questions
What Are NAD+ Supplements and Do They Actually Slow Aging?
NAD+ stands for nicotinamide adenine dinucleotide, a coenzyme found in every cell that plays a central role in energy metabolism, DNA repair, and cellular signaling. Your body produces it naturally, but levels drop substantially as you age. The two most popular supplement precursors are NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), which the body converts into NAD+ through different metabolic pathways. A head-to-head human trial found that after 14 days, both NMN and NR approximately doubled circulating NAD+ levels, while plain nicotinamide had no significant effect. Interestingly, the study found that gut bacteria convert NMN and NR to nicotinic acid, which then boosts NAD+, meaning the pathway is more complicated than supplement companies typically suggest.
The animal research is genuinely impressive. Studies in mice have shown cardiovascular improvements, reversed mitochondrial dysfunction, improved muscle function, and in some cases extended lifespan. But here is the critical distinction that gets lost in marketing materials: no human evidence currently exists that NAD+ supplementation extends lifespan. In obese, insulin-resistant men, 2 grams of NR failed to improve insulin sensitivity or body composition. In healthy obese adults, 1 gram of NR did not improve insulin sensitivity or mitochondrial health. The leap from mouse to human has produced mostly disappointment so far, and anyone telling you otherwise is either not reading the studies or selling you something.
What the Latest Clinical Trials Actually Found
The most encouraging human data comes from a 12-week randomized controlled trial showing that NMN at 250 mg per day improved sleep quality and walking speed in older adults, while also reducing LDL cholesterol, body weight, and diastolic blood pressure. These are modest but real outcomes, and sleep quality in particular matters for brain health and dementia risk. However, a single trial with a small sample is not enough to build clinical recommendations on, and the improvements were measured against specific baselines in a specific population of older adults. A newer entrant, NMNH (a reduced form of NMN), generated excitement when a 90-day trial at 500 mg per day reportedly tripled circulating NAD+ levels. But those results are unpublished and sponsor-reported only, which means they have not been peer-reviewed or independently verified.
In the supplement industry, sponsor-reported data that never makes it through peer review is a red flag, not a selling point. If you are weighing these results against the cost of supplements, keep in mind that raising blood NAD+ levels is not the same as demonstrating a health benefit. Your blood levels go up. The question is whether that matters for your brain, your heart, or your longevity, and that question remains largely unanswered. The Lancet eClinicalMedicine trial on NR for long-COVID is notable because it used a rigorous double-blind, placebo-controlled design and a high dose of 2,000 mg per day, and it specifically evaluated cognitive outcomes. This is the kind of study the field needs more of, but one trial does not settle a debate that spans dozens of contested claims.
The Financial Conflicts Behind the NAD+ Debate
The NAD+ supplement space is unusually compromised by financial conflicts of interest, and understanding who profits from what claim is essential for evaluating the science. David Sinclair, the Harvard geneticist who is the most prominent advocate for NAD+ supplementation, takes roughly 1,000 mg of NMN daily and co-founded Metro Biotech, which develops NMN-based therapeutics. Sinclair faced serious criticism after claiming that his dog supplement was “proven to reverse aging.” Aging biologist Matt Kaeberlein called that claim “a lie,” and Sinclair subsequently resigned from the related organization.
On the other side, Charles Brenner, who advises ChromaDex (the company behind Tru Niagen, an NR supplement), has publicly criticized Sinclair’s recommendation that people take metformin for anti-aging, noting it can blunt the beneficial effects of exercise in people without type 2 diabetes. That is a legitimate scientific critique, but it also comes from someone with a financial stake in a competing product. When both the leading NMN advocate and the leading NR advocate have direct financial ties to supplement companies, it becomes nearly impossible for a consumer to take any expert pronouncement at face value. The smartest approach is to read the trial data directly and ignore the personalities.
How Much Do NAD+ Supplements Cost and Are They Worth the Price?
Oral NAD+ supplements typically run between $30 and $100 per month, with per-serving costs ranging from about $0.73 to over $3.00. Specific products vary widely: Thorne NiaCel 400 costs roughly $70 for 60 servings, Elysium Basis runs about $65 for 30 servings, and Circle of Nature comes in around $39 for a 30-day supply. If you are considering more aggressive delivery methods, NAD+ IV infusions cost between $250 and $1,500 per session, and NAD+ injections run $40 to $200 per session. Over a year, even oral supplements can cost $360 to $1,200, and IV therapy can run into the tens of thousands.
The tradeoff calculation depends entirely on what you expect to gain. If the 12-week NMN trial results on sleep quality and cardiovascular markers hold up in larger studies, $40 per month for a supplement that modestly improves sleep and reduces blood pressure might be reasonable for some people. But if you are spending $100 per month hoping to prevent dementia or reverse aging, the current evidence does not support that investment. For brain health specifically, the money might be better spent on interventions with stronger evidence: regular aerobic exercise, consistent sleep habits, social engagement, and management of cardiovascular risk factors. These are not as exciting as a pill, but they have decades of human data behind them.
Regulatory Chaos and What the FDA’s Reversal Means for Consumers
The regulatory history of NMN is a cautionary tale about how commercial interests shape the supplement landscape. In November 2022, the FDA excluded NMN from permitted dietary supplements after Metro Biotech, David Sinclair’s own company, had registered NMN as an investigational new drug. In other words, the same researcher promoting NMN as a supplement had a company that effectively helped get it pulled from the supplement market so it could be developed as a pharmaceutical. The Natural Products Association sued the FDA in August 2024, and on September 29, 2025, the FDA reversed course and confirmed NMN is lawful for use in dietary supplements, ending roughly three years of regulatory uncertainty.
As of December 2025, NMN is classified as a New Dietary Ingredient, requiring premarket notification before marketing but not FDA approval for safety or efficacy. This means manufacturers do not have to prove their product works before selling it to you. No long-term safety studies exist on NAD+ boosters determining optimal dose, treatment period, or tissue specificity. Common side effects reported in short-term use include headaches, dizziness, and nervousness. These are generally mild, but the absence of long-term data is a genuine concern for anyone considering years of daily supplementation, which is what most anti-aging protocols assume.
NAD+ and Brain Health — What Dementia Caregivers Should Know
For families dealing with dementia or cognitive decline, NAD+ supplements are often pitched as a way to protect or restore brain function. The biological rationale is not unreasonable: NAD+ is involved in mitochondrial function and DNA repair, both of which are impaired in neurodegenerative disease. But rationale is not evidence, and there are currently no published clinical trials demonstrating that NAD+ precursors prevent, slow, or reverse Alzheimer’s disease or other dementias in humans. If a supplement company or wellness influencer claims otherwise, they are extrapolating from cell cultures and mouse models, which is exactly the kind of reasoning that has failed repeatedly in Alzheimer’s drug development.
What might matter for brain health in this context is the downstream effect on sleep. Poor sleep is one of the strongest modifiable risk factors for dementia, and the 12-week NMN trial did show improvements in sleep quality. If future, larger trials confirm that finding, there could be an indirect argument for NAD+ supplementation as part of a broader brain health strategy. But that is a far cry from the “anti-aging miracle” framing that dominates the marketing.
Where the Science Goes From Here
The next few years should clarify whether NAD+ supplementation offers real clinical benefits or remains an expensive way to change a number on a blood test. Larger, longer, and more rigorously designed trials are underway, and the FDA’s decision to allow NMN as a dietary supplement means more products will enter the market, which could drive prices down and increase pressure for quality data. The emergence of NMNH as a potentially more potent precursor adds another variable, though unpublished, sponsor-reported results should be treated with skepticism until they survive peer review.
For now, the honest assessment is that NAD+ supplements are biologically interesting but clinically unproven for most of the outcomes people care about. If you choose to try them, do so with realistic expectations, awareness of the financial conflicts shaping the conversation, and a commitment to the lifestyle interventions that actually have strong evidence behind them. The most important thing you can do for your brain is not something you buy in a bottle.
Conclusion
NAD+ supplements occupy a frustrating middle ground. The basic science is sound: NAD+ levels do decline with age, precursors like NMN and NR do raise those levels, and there are plausible mechanisms linking NAD+ to aging and neurodegeneration. But plausible mechanisms are not proof of benefit, and the human trial data so far shows modest improvements in some outcomes while failing to deliver on the bigger promises of anti-aging and disease prevention.
The field is further muddied by financial conflicts on every side of the debate. If you or a loved one is navigating cognitive decline, your time and money are better directed toward interventions with established evidence: physical activity, sleep optimization, blood pressure management, and social connection. NAD+ supplements may eventually earn a place in that toolkit, but they have not earned it yet. Stay skeptical, follow the trial data rather than the personalities, and do not let the promise of a simple fix distract from the harder work that actually matters.
Frequently Asked Questions
Can NAD+ supplements prevent or treat Alzheimer’s disease?
No human clinical trial has demonstrated that NAD+ precursors prevent, slow, or reverse Alzheimer’s or other dementias. The biological rationale exists, but evidence in humans does not yet support this use.
Is NMN or NR better for raising NAD+ levels?
A head-to-head human trial found both NMN and NR approximately doubled circulating NAD+ levels after 14 days, with no clear winner. The study revealed that gut bacteria convert both into nicotinic acid, which then boosts NAD+. Plain nicotinamide had no significant effect.
Are NAD+ supplements safe to take long-term?
Short-term side effects are generally mild, including headaches, dizziness, and nervousness. However, no long-term safety studies exist determining optimal dose, treatment period, or tissue-specific effects. Anyone considering years of daily use is operating without safety data.
Why was NMN banned and then unbanned by the FDA?
In November 2022, the FDA excluded NMN from dietary supplements after Metro Biotech registered it as an investigational new drug. After a lawsuit by the Natural Products Association in August 2024, the FDA reversed its position on September 29, 2025, confirming NMN is lawful in dietary supplements. It is now classified as a New Dietary Ingredient requiring premarket notification.
How much do NAD+ supplements cost per month?
Oral supplements typically cost $30 to $100 per month, with per-serving costs from about $0.73 to over $3.00. NAD+ IV infusions cost $250 to $1,500 per session, and injections run $40 to $200 per session.
Do NAD+ supplements actually work for anti-aging?
They reliably raise blood NAD+ levels, but a meta-analysis of randomized controlled trials found that most clinically relevant outcomes were not significantly different from placebo. No human evidence exists that they extend lifespan. Some modest benefits like improved sleep quality and walking speed have been observed in individual trials.
